Loading...
XNYSOHI
Market cap10bUSD
Dec 26, Last price  
38.15USD
1D
0.69%
1Q
-7.04%
Jan 2017
22.17%
Name

Omega Healthcare Investors Inc

Chart & Performance

D1W1MN
XNYS:OHI chart
P/E
42.52
P/S
10.84
EPS
0.90
Div Yield, %
6.25%
Shrs. gr., 5y
3.61%
Rev. gr., 5y
1.50%
Revenues
950m
+8.14%
90,451,000105,812,000135,693,000159,558,000193,762,000197,438,000258,321,000292,204,000350,460,000418,714,000504,787,000743,617,000900,827,000908,385,000881,682,000928,830,000892,381,0001,062,809,000878,244,000949,740,000
Net income
242m
-43.27%
16,738,00036,688,00055,697,00069,374,00078,137,00082,111,00058,436,00052,606,000120,698,000172,521,000221,349,000224,524,000366,415,000100,419,000281,578,000341,123,000159,327,000416,739,000426,927,000242,180,000
CFO
618m
-1.28%
54,362,00072,957,00062,811,00084,542,00089,328,000147,223,000157,563,000169,771,000208,271,000279,949,000337,540,000463,885,000625,791,000577,912,000499,373,000553,747,000708,256,000722,136,000625,727,000617,736,000
Dividend
Aug 05, 20240.67 USD/sh
Earnings
Feb 05, 2025

Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
URL
https://www.omegahealthcare.com/
IPO date
Aug 07, 1992
Employees
52
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
949,740
8.14%
878,244
-17.37%
1,062,809
19.10%
Cost of revenue
188,472
84,897
76,888
Unusual Expense (Income)
NOPBT
761,268
793,347
985,921
NOPBT Margin
80.16%
90.33%
92.77%
Operating Taxes
6,255
4,561
3,840
Tax Rate
0.82%
0.57%
0.39%
NOPAT
755,013
788,786
982,081
Net income
242,180
-43.27%
426,927
2.44%
416,739
161.56%
Dividends
(643,867)
(632,893)
(637,648)
Dividend yield
8.38%
9.27%
8.82%
Proceeds from repurchase of equity
336,402
(134,155)
273,932
BB yield
-4.38%
1.96%
-3.79%
Debt
Debt current
426,626
19,246
96
Long-term debt
4,733,709
5,267,308
5,281,769
Deferred revenue
5,601,881
(248,483)
Other long-term liabilities
1,508
(5,642,849)
248,483
Net debt
4,529,116
4,810,531
4,596,760
Cash flow
Cash from operating activities
617,736
625,727
722,136
CAPEX
(47,221)
(95,064)
Cash from investing activities
(770)
442,853
(524,173)
Cash from financing activities
(473,310)
(789,447)
(341,117)
FCF
1,830,069
155,374
1,372,189
Balance
Cash
442,810
297,103
20,534
Long term investments
188,409
178,920
664,571
Excess cash
583,732
432,111
631,965
Stockholders' equity
(2,908,907)
(2,510,921)
(2,319,340)
Invested Capital
11,789,802
11,560,069
11,681,198
ROIC
6.47%
6.79%
8.54%
ROCE
8.57%
8.73%
10.52%
EV
Common stock shares outstanding
250,451
244,290
244,338
Price
30.66
9.70%
27.95
-5.54%
29.59
-18.53%
Market cap
7,678,828
12.46%
6,827,906
-5.56%
7,229,961
-15.33%
EV
12,395,651
11,832,350
12,028,109
EBITDA
1,080,950
1,125,754
1,327,935
EV/EBITDA
11.47
10.51
9.06
Interest
235,529
233,244
234,604
Interest/NOPBT
30.94%
29.40%
23.80%